Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 241 of 1,261
  1. US 11433038

    High concentration medicant solutions for treating neurological disorders

    The Regents of the University of Colorado · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  2. US 11435366

    Noninvasive method to quantify kidney function and functional decline

    The Regents of the University of California · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  3. US 11434293

    Anti TRBC1 antigen binding domains

    AUTOLUS LIMITED · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  4. US 11434272

    Anti-human papillomavirus 16 E7 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  5. US 11433131

    Adoptive cell therapy using spherical nucleic acids (SNAs)

    Northwestern University · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  6. US 11433091

    Methods and compositions for administration of iron

    American Regent, Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  7. US 11433025

    Oil foamable carriers and formulations

    Vyne Therapeutics Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  8. US 11433143

    Nano-enabled immunotherapy in cancer

    The Regents of the University of California · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  9. US 11435349

    CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs

    The Regents of the University of California · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  10. US 11434505

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  11. US 11434300

    Methods and antibody compositions for tumor treatment

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  12. US 11434304

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  13. US 11434487

    Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  14. US 11434301

    Anti-CD46 antibodies and methods of use

    The Regents of the University of California · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  15. US 11434278

    Protein-polymer-drug conjugates

    Asana BioSciences, LLC · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  16. US 11434268

    Vascular endothelial growth factor antagonists

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  17. US 11434233

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  18. US 11434485

    Synthetic transfer RNA with extended anticodon loop

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  19. US 11434297

    CD123-binding polypeptides and uses thereof

    Inhibrx, Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  20. US 11433102

    Compositions and methods for treating Parkinson's disease (PD) and related disorders

    Finch Therapeutics Holdings LLC · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  21. US 11433097

    Methods of using tumor infiltrating lymphocytes in double-refractory melanoma

    Iovance Biotherapeutics, Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  22. US 11433103

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  23. US 11433126

    Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  24. US 11433118

    Long-acting VEGF inhibitors for intraocular neovascularization

    The Regents of the University of California · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.